[{"address1": "1065 East Hillsdale Boulevard", "address2": "Suite 100", "city": "Foster City", "state": "CA", "zip": "94404", "country": "United States", "phone": "650 525 5535", "fax": "650 275 4254", "website": "https://www.ternspharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule product candidates for the treatment of oncology and obesity. The company develops TERN-701, an allosteric BCR-ABL tyrosine kinase inhibitor (TKI) that is in Phase 1 clinical trial for chronic myeloid leukemia (CML), a form of cancer that starts in bone marrow. It also develops TERN-501, a thyroid hormone receptor beta agonist with enhanced liver distribution and metabolic stability that is in Phase IIa clinical trial for the treatment of metabolic dysfunction-associated steatohepatitis (MASH); and TERN-601, a small-molecule Glucagon-Like Peptide-1 receptor agonist program that is intended to orally be administered for obesity, as well as TERN-800 series of small-molecule glucose-dependent insulinotropic polypeptide receptor (GIPR) modulators for obesity. The company was incorporated in 2016 and is headquartered in Foster City, California.", "fullTimeEmployees": 59, "companyOfficers": [{"maxAge": 1, "name": "Ms. Amy L. Burroughs M.B.A.", "age": 53, "title": "CEO & Director", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 1007081, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Melita Sun Jung", "age": 47, "title": "Chief Business Officer", "yearBorn": 1977, "fiscalYear": 2024, "totalPay": 508886, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Andrew W. Gengos", "age": 60, "title": "Chief Financial Officer", "yearBorn": 1964, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jeffrey R. Jasper Ph.D.", "title": "Senior Vice President of Research", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Emil T. Kuriakose M.D.", "age": 44, "title": "Chief Medical Officer", "yearBorn": 1980, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Scott  Harris", "title": "Chief Development Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Debra  Sieminski", "title": "Senior Vice President of Medical Affairs", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. James  Kanter", "title": "Senior VP of CMC", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Yasameen  Qazen", "title": "Senior VP of Regulatory Affairs & Quality Assurance", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David Eric Strauss", "age": 38, "title": "VP of Finance & Controller", "yearBorn": 1986, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 7, "compensationRisk": 8, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1746057600, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 3.025, "open": 3.03, "dayLow": 2.93, "dayHigh": 3.11, "regularMarketPreviousClose": 3.025, "regularMarketOpen": 3.03, "regularMarketDayLow": 2.93, "regularMarketDayHigh": 3.11, "payoutRatio": 0.0, "beta": -0.172, "forwardPE": -2.2230215, "volume": 275966, "regularMarketVolume": 275966, "averageVolume": 1157103, "averageVolume10days": 992330, "averageDailyVolume10Day": 992330, "bid": 3.04, "ask": 3.14, "bidSize": 1, "askSize": 1, "marketCap": 269870720, "fiftyTwoWeekLow": 1.865, "fiftyTwoWeekHigh": 11.4, "fiftyDayAverage": 3.0055, "twoHundredDayAverage": 5.804025, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -92741672, "profitMargins": 0.0, "floatShares": 53712485, "sharesOutstanding": 87297600, "sharesShort": 5578525, "sharesShortPriorMonth": 5947873, "sharesShortPreviousMonthDate": 1741910400, "dateShortInterest": 1744675200, "sharesPercentSharesOut": 0.0639, "heldPercentInsiders": 0.0025099998, "heldPercentInstitutions": 1.0279499, "shortRatio": 4.54, "shortPercentOfFloat": 0.07, "impliedSharesOutstanding": 87336800, "bookValue": 3.97, "priceToBook": 0.7783375, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -88853000, "trailingEps": -1.12, "forwardEps": -1.39, "enterpriseToEbitda": 0.913, "52WeekChange": -0.48378837, "SandP52WeekChange": 0.08001411, "quoteType": "EQUITY", "currentPrice": 3.09, "targetHighPrice": 34.0, "targetLowPrice": 7.5, "targetMeanPrice": 18.9375, "targetMedianPrice": 18.5, "recommendationMean": 1.8, "recommendationKey": "buy", "numberOfAnalystOpinions": 8, "totalCash": 358164000, "totalCashPerShare": 4.103, "ebitda": -101552000, "totalDebt": 1347000, "quickRatio": 22.886, "currentRatio": 23.138, "debtToEquity": 0.389, "returnOnAssets": -0.20134, "returnOnEquity": -0.29557, "freeCashflow": -43260376, "operatingCashflow": -70016000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "TERN", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1612535400000, "fiftyTwoWeekLowChange": 1.2249999, "fiftyTwoWeekLowChangePercent": 0.6568364, "fiftyTwoWeekRange": "1.865 - 11.4", "fiftyTwoWeekHighChange": -8.309999, "fiftyTwoWeekHighChangePercent": -0.72894734, "fiftyTwoWeekChangePercent": -48.378838, "earningsTimestamp": 1742501100, "regularMarketChange": 0.06499982, "regularMarketDayRange": "2.93 - 3.11", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 1157103, "shortName": "Terns Pharmaceuticals, Inc.", "longName": "Terns Pharmaceuticals, Inc.", "earningsTimestampStart": 1747053000, "earningsTimestampEnd": 1747398600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.12, "epsForward": -1.39, "epsCurrentYear": -1.18366, "priceEpsCurrentYear": -2.6105468, "fiftyDayAverageChange": 0.084499836, "fiftyDayAverageChangePercent": 0.028115068, "twoHundredDayAverageChange": -2.7140253, "twoHundredDayAverageChangePercent": -0.46761087, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-02-05", "averageAnalystRating": "1.8 - Buy", "cryptoTradeable": false, "corporateActions": [], "regularMarketTime": 1746724509, "exchange": "NMS", "messageBoardId": "finmb_558294166", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 2.1487544, "regularMarketPrice": 3.09, "marketState": "REGULAR", "displayName": "Terns Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-05-08"}]